Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Dyslipidemia is an independent risk factor for type 2 diabetes, although exactly which of the many plasma lipids contribute to this remains unclear. We therefore investigated whether lipid profiling can inform diabetes prediction by performing liquid chromatography/mass spectrometry-based lipid profiling in 189 individuals who developed type 2 diabetes and 189 matched disease-free individuals, with over 12 years of follow up in the Framingham Heart Study. We found that lipids of lower carbon number and double bond content were associated with an increased risk of diabetes, whereas lipids of higher carbon number and double bond content were associated with decreased risk. This pattern was strongest for triacylglycerols (TAGs) and persisted after multivariable adjustment for age, sex, BMI, fasting glucose, fasting insulin, total triglycerides, and HDL cholesterol. A combination of 2 TAGs further improved diabetes prediction. To explore potential mechanisms that modulate the distribution of plasma lipids, we performed lipid profiling during oral glucose tolerance testing, pharmacologic interventions, and acute exercise testing. Levels of TAGs associated with increased risk for diabetes decreased in response to insulin action and were elevated in the setting of insulin resistance. Conversely, levels of TAGs associated with decreased diabetes risk rose in response to insulin and were poorly correlated with insulin resistance. These studies identify a relationship between lipid acyl chain content and diabetes risk and demonstrate how lipid profiling could aid in clinical risk assessment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, specific TAGs containing palmitate or stearate, i.e. TAG 48:0, 50:0, 48:1 and 50:1, have been associated with the severity of MASLD and with an increased risk of developing T2D.105,106”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [106]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Rimm, E. B., Giovannucci, E. L., Stampfer, M. J., Colditz, G. A., Litin, L. B., & Willett, W. C. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116211 · Cited by 2,104
AN INVESTIGATION OF CORONARY HEART DISEASE IN FAMILIES
KANNEL, W. B., FEINLEIB, M., McNAMARA, P. M., GARRISON, R. J., & CASTELLI, W. P. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112813 · Cited by 1,645
The emerging field of lipidomics
Wenk, M. R. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1776 · Cited by 1,330
STRUCTURE, FUNCTION, AND DIETARY REGULATION OF Δ6, Δ5, AND Δ9 DESATURASES
Nakamura, M. T., & Nara, T. Y. (2004) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.24.121803.063211 · Cited by 1,073
Guillou, H., Zadravec, D., Martin, P. G. P., & Jacobsson, A. (2010) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.12.002 · Cited by 865
Invited Review: Effects of acute exercise and exercise training on insulin resistance
Henriksen, E. J. (2002) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01219.2001 · Cited by 535
Research works printed but not linked: 1
- German, 2007, Curr Opin Lipidol., 18, 66
Cited by
Items 101–200 of 658
Metabolomic profiles as reliable biomarkers of dietary composition
Esko, T., Hirschhorn, J. N., Feldman, H. A., Hsu, Y.-H. H., Deik, A., Clish, C. B., Ebbeling, C. B., & Ludwig, D. S. (2017) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.144428 · Cited by 127
Self-citationSanders, F. W. B., Acharjee, A., Walker, C., Marney, L., Roberts, L. D., Imamura, F., Jenkins, B., Case, J., Ray, S., Virtue, S., et al. (2018) · Genome Biology · doi:10.1186/s13059-018-1439-8 · Cited by 114
“One of the most reproducible set of prospective biomarkers of IR and T2DM are TAGs with shorter, more saturated FAs, first reported in the Framingham cohort [10] and since reproduced in a number of large cohort studies as well as the investigation of rarer patient groups of T2DM [11, 12, 14, 19, 35].”
BackgroundDrosophila gains traction as a repurposed tool to investigate metabolism
Padmanabha, D., & Baker, K. D. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.03.011 · Cited by 139
Pirro, V., Roth, K. D., Lin, Y., Willency, J. A., Milligan, P. L., Wilson, J. M., Ruotolo, G., Haupt, A., Newgard, C. B., & Duffin, K. L. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab722 · Cited by 113
Simons, B., Kauhanen, D., Sylvänne, T., Tarasov, K., Duchoslav, E., & Ekroos, K. (2012) · Metabolites · doi:10.3390/metabo2010195 · Cited by 110
“obtained ies [12], h ach of the d positions a”
BackgroundPlacing epidemiological results in the context of multiplicity and typical correlations of exposures
Patel, C. J., & Ioannidis, J. P. A. (2014) · Journal of Epidemiology & Community Health · doi:10.1136/jech-2014-204195 · Cited by 117
Metabolic Architecture of Acute Exercise Response in Middle-Aged Adults in the Community
Nayor, M. G., Shah, R. V., Miller, P. E., Blodgett, J. B., Tanguay, M., Pico, A. R., Murthy, V. L., Malhotra, R. K., Houstis, N. E., Deik, A., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.050281 · Cited by 117
Self-citationClinical metabolomics paves the way towards future healthcare strategies
Collino, S., Martin, F. J., & Rezzi, S. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04216.x · Cited by 108
Toledo, E., Wang, D. D., Ruiz‐Canela, M., Clish, C. B., Razquín, C., Zheng, Y., Guasch‐Ferré, M., Hruby, A., Corella, D., Gómez‐Gracia, E., et al. (2017) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.151159 · Cited by 121
Self-citationMouse lipidomics reveals inherent flexibility of a mammalian lipidome
Surma, M. A., Gerl, M. J., Herzog, R., Helppi, J., Simons, K., & Klose, C. D. (2021) · Scientific Reports · doi:10.1038/s41598-021-98702-5 · Cited by 110
Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease
McGlinchey, A. J., Govaere, O., Geng, D., Ratziu, V., Allison, M., Bousier, J., Petta, S., de Oliviera, C., Bugianesi, E., Schattenberg, J. M., et al. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100477 · Cited by 105
“The TGs that increase in NASH include those TGs with low carbon number and double bond count, which were previously found to be associated with de novo lipogenesis,(25) insulin resistance,(26) NAFLD,(10) and with increased risk of type 2 diabetes.(27) As compared with other assessments performed at biopsy (including s…”
ResultObesity and diabetes related plasma amino acid alterations
Zhou, Y., Qiu, L., Xiao, Q., Wang, Y., Meng, X., Xu, R. H., Wang, S., & Na, R. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.05.045 · Cited by 116
“A recent publication suggested that differences in total triglycerides and HDL cholesterol are predictive for diabetes development [33], but less is known about”
BackgroundThe role of ChREBP in carbohydrate sensing and NAFLD development
Régnier, M., Carbinatti, T., Parlati, L., Benhamed, F., & Postic, C. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00809-4 · Cited by 101
Gender, Contraceptives and Individual Metabolic Predisposition Shape a Healthy Plasma Lipidome
Sales, S., Graessler, J., Ciucci, S., Al-Atrib, R., Vihervaara, T., Schuhmann, K., Kauhanen, D., Sysi-Aho, M., Bornstein, S. R., Bickle, M., et al. (2016) · Scientific Reports · doi:10.1038/srep27710 · Cited by 103
Walford, G. A., Porneala, B. C., Dauriz, M., Vassy, J. L., Cheng, S., Rhee, E. P., Wang, T. J., Meigs, J. B., Gerszten, R. E., & Florez, J. C. (2014) · Diabetes Care · doi:10.2337/dc14-0560 · Cited by 99
“Measurement methods for amino acid and intermediary metabolites (12,14,15), as well as lipid metabolites (13), have previously been reported.”
Self-citationLipidomics from an analytical perspective
Sandra, K., & Sandra, P. J. F. (2013) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2013.06.010 · Cited by 115
Lankinen, M. A., Schwab, U., Kolehmainen, M., Paananen, J., Nygrén, H., Seppänen‐Laakso, T., Poutanen, K. S., Hyötyläinen, T., Risérus, U., Savolainen, M. J., et al. (2016) · Journal of Nutrition · doi:10.3945/jn.115.220459 · Cited by 110
Metabolic profiling of polycystic ovary syndrome reveals interactions with abdominal obesity
Couto Alves, A., Valcarcel, B., Mäkinen, V.-P., Morin-Papunen, L., Sebert, S., Kangas, A. J., Soininen, P., Das, S., De Iorio, M., Coin, L., et al. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.126 · Cited by 96
“Recent metabolic profiling studies have discovered novel molecular markers associated with the risk for diabetes [14, 15] and cardiovascular disease [16-18].”
Plasma metabolite profiles related to plant-based diets and the risk of type 2 diabetes
Wang, F., Baden, M. Y., Guasch‐Ferré, M., Wittenbecher, C., Li, J., Li, Y., Wan, Y., Bhupathiraju, S. N., Tobias, D. K., Clish, C. B., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05692-8 · Cited by 105
“Physiologic and pharmacologic experiments also showed that levels of these TAGs decreased in response to insulin action and were elevated in the setting of insulin resistance [41].”
BackgroundSelf-citationKoulman, A., Prentice, P. M., Wong, M. C. Y., Matthews, L., Bond, N. J., Eiden, M. J., Griffin, J. L., & Dunger, D. B. (2014) · Metabolomics · doi:10.1007/s11306-014-0628-z · Cited by 99
“Since most lipid profiling studies based on plasma or serum use venepuncture (Floegel et al. 2012; Rhee et al. 2011), we determined if there was a difference in whole blood collected by venepuncture or collected from the capillary bed (heel prick or finger prick).”
InfluentialAfshinnia, F., Rajendiran, T. M., Karnovsky, A., Soni, T., Wang, X., Xie, D., Yang, W. P., Shafi, T., Weir, M. R., He, J., et al. (2016) · Kidney International Reports · doi:10.1016/j.ekir.2016.08.007 · Cited by 94
Self-citationLipid droplets and fatty acid‐induced lipotoxicity: in a nutshell
Obaseki, E., Adebayo, D., Bandyopadhyay, S., & Hariri, H. H. (2024) · FEBS Letters · doi:10.1002/1873-3468.14808 · Cited by 107
Qiu, G., Zheng, Y., Wang, H., Sun, J., Ma, H., Xiao, Y., Li, Y., Yuan, Y., Yang, H., Li, X., et al. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw221 · Cited by 89
Lipidomic profiling identifies signatures of metabolic risk
Yin, X., Willinger, C. M., Keefe, J. A., Liu, J., Fernández‐Ortíz, A., Ibáñez, B., Peñalvo, J. L., Adourian, A. S., Chen, G., Corella, D., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.10.046 · Cited by 95
Self-citationLipid remodeling of adipose tissue in metabolic health and disease
Cho, Y. K., Lee, S., Lee, J. R., Doh, J., Park, J., Jung, Y., & Lee, Y. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01071-4 · Cited by 109
“Furthermore, elevated PC 38:6 is associated with a decreased risk of diabetes 47 .”
BackgroundRusso, S. B., Tidhar, R., Futerman, A. H., & Cowart, L. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.428185 · Cited by 90
“Recent studies have indicated that plasma lipid profiles in obese individuals demonstrate a shift toward shorter, saturated acyl chains, such as myristate, which can be utilized by SPTLC3 for sphingoid base synthesis (7, 48).”
BackgroundLu, L., Koulman, A., Petry, C. J., Jenkins, B., Matthews, L., Hughes, I. A., Acerini, C. L., Ong, K. K., & Dunger, D. B. (2016) · Diabetes Care · doi:10.2337/dc16-0863 · Cited by 87
“TG(48:1) has been implicated with type 2 diabetes risk in the Framingham cohort (27), and PC(32:1) levels were raised in AusDiab subjects with type 2 diabetes (28).”
Pretorius, E., Bester, J., Vermeulen, N., Alummoottil, S., Soma, P., Buys, A. V., & Kell, D. B. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0192-5 · Cited by 95
“insulin resistance is found in type II diabetes [14-17].”
BackgroundLappas, M., Mundra, P. A., Wong, G., Huynh, K., Jinks, D., Georgiou, H. M., Permezel, M., & Meikle, P. J. (2015) · Diabetologia · doi:10.1007/s00125-015-3587-7 · Cited by 96
Lipidomics in longevity and healthy aging
González-Covarrubias, V. (2013) · Biogerontology · doi:10.1007/s10522-013-9450-7 · Cited by 95
Metabolomics Signatures of Aging: Recent Advances
Adav, S. S., & Wang, Y. (2021) · Aging and Disease · doi:10.14336/ad.2020.0909 · Cited by 110
“low-density lipoprotein (LDL) particles are the main carriers of sphingomyelins and ceramides, while the role of triglyceride and sphingomyelin species has been identified in insulin resistance ([49] and in AD [50], and many other diseases.”
BackgroundOttestad, I., Hassani, S., Borge, G. I., Kohler, A., Vogt, G., Hyötyläinen, T., Orešič, M., Brønner, K. W., Holven, K. B., Ulven, S. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042550 · Cited by 83
“Lipid profiling has identified a relation between lipid acyl chain structure and risk of disease [22].”
BackgroundProteomic and Metabolomic Correlates of Healthy Dietary Patterns: The Framingham Heart Study
Walker, M. E., Song, R. J., Xu, X., Gerszten, R. E., Ngo, D., Clish, C. B., Corlin, L., Ma, J., Xanthakis, V., Jacques, P. F., et al. (2020) · Nutrients · doi:10.3390/nu12051476 · Cited by 89
Self-citationSystems biology strategies to study lipidomes in health and disease
Hyötyläinen, T., & Orešič, M. (2014) · Progress in Lipid Research · doi:10.1016/j.plipres.2014.06.001 · Cited by 90
Fatty acids and their role in type‑2 diabetes (Review)
Shetty, S. S., & Kumari, S. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10138 · Cited by 96
“It was demonstrated that specific combinations of FAs within PL and TG exhibited the strongest association with the risk of T2DM, particularly shorter saturated FAs (SFAs) (15).”
BackgroundMetabolomics Insights into Osteoporosis Through Association With Bone Mineral Density
Zhang, X., Xu, H., Li, G. H., Long, M. T., Cheung, C., Vasan, R. S., Hsu, Y., Kiel, D. P., & Liu, C. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4240 · Cited by 82
“on the collected plasma samples and the concentration of plasma metabolites was assessed using a liquid chromatography / mass spectrometry (LS/MS) platform as previously described.((16,17)) We removed metabolites with a high missing rate (≥ 20%) and replaced the missing values in the remaining metabolites by the half…”
MethodSelf-citationHuang, L., Lin, J.-S., Aris, I. M., Yang, G., Chen, W., & Li, L. (2019) · Nutrients · doi:10.3390/nu11050998 · Cited by 86
Hinterwirth, H. H., Stegemann, C., & Mayr, M. (2014) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.114.000550 · Cited by 78
Overview of Lipidomic Analysis of Triglyceride Molecular Species in Biological Lipid Extracts
Han, X., & Ye, H. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c07175 · Cited by 85
Proteomic profiling reveals biomarkers and pathways in type 2 diabetes risk
Ngo, D., Benson, M. D., Long, J. Z., Chen, Z., Wang, R., Nath, A. K., Keyes, M. J., Shen, D., Sinha, S., Kuhn, E. W., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.144392 · Cited by 83
Self-citationWang, Q., Wu, Y., Zhang, W., Shen, T., Li, H., Wu, J., Zhang, L., Qin, L., Chen, R., Gu, W., et al. (2022) · Chemosphere · doi:10.1016/j.chemosphere.2022.136591 · Cited by 88
Razquín, C., Liang, L., Toledo, E., Clish, C. B., Ruiz‐Canela, M., Zheng, Y., Wang, D. D., Corella, D., Castañer, O., Ros, E., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.10.026 · Cited by 89
“Associations between some lipid metabolites and body mass index (BMI) [3], diabetes [4] and CVD [5] have been reported in studies of the lipidome.”
BackgroundSelf-citationWang, F., Tessier, A., Liang, L., Wittenbecher, C., Haslam, D. E., Fernández-Duval, G., Eliassen, A. H., Rexrode, K. M., Tobias, D. K., Li, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41515-z · Cited by 86
Self-citationA systematic survey of lipids across mouse tissues
Jain, M., Ngoy, S., Sheth, S. A., Swanson, R. A., Rhee, E. P., Liao, R., Clish, C. B., Mootha, V. K., & Nilsson, R. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00371.2013 · Cited by 74
Self-citationBiochemical and High Throughput Microscopic Assessment of Fat Mass in Caenorhabditis Elegans
Pino, E. C., Webster, C. M., Carr, C. E., & Soukas, A. A. (2013) · Journal of Visualized Experiments · doi:10.3791/50180 · Cited by 84
An exome array study of the plasma metabolome
Rhee, E. P., Yang, Q., Yu, B., Liu, X., Cheng, S., Deik, A., Pierce, K. A., Bullock, K., Ho, J. E., Levy, D., et al. (2016) · Nature Communications · doi:10.1038/ncomms12360 · Cited by 71
Self-citationThe roles of dietary lipids and lipidomics in gut-brain axis in type 2 diabetes mellitus
Ağagündüz, D., İçer, M. A., Yeşildemir, Ö., Koçak, T., Koçyiğit, E., & Capasso, R. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04088-5 · Cited by 89
Altered Metabolome of Lipids and Amino Acids Species: A Source of Early Signature Biomarkers of T2DM
Hameed, A., Mojsak, P., Buczyńska, A., Suleria, H. A. R., Kretowski, A. J., & Ciborowski, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072257 · Cited by 89
“A strong association of TG with a single double bond and low carbon number with the risk of T2DM has been witnessed by Rhee and his colleagues [66].”
BackgroundWhat Have Metabolomics Approaches Taught Us About Type 2 Diabetes?
González-Franquesa, A., Burkart, A., ISGANAITIS, E. M., & Patti, M. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0763-1 · Cited by 77
Dunn, W. B., Goodacre, R., Neyses, L., & Mamas, M. A. (2011) · Bioanalysis · doi:10.4155/bio.11.223 · Cited by 80
Exploring New Drug Targets for Type 2 Diabetes: Success, Challenges and Opportunities
Kanwal, A., Kanwar, N., Bharati, S., Srivastava, P., Singh, S. P., & Amar, S. (2022) · Biomedicines · doi:10.3390/biomedicines10020331 · Cited by 88
“This modulation increases intracellular acylcarnitine, diacylglycerol and triacylglycerol levels which results in increased triglycerides in blood circulation and an accumulation in liver tissue [30,31].”
BackgroundObesity, Gut Microbiota, and Metabolome: From Pathophysiology to Nutritional Interventions
Puljiz, Z., Kumrić, M., Vrdoljak, J., Martinović, D., Kurir, T. T., Krnic, M. O., Urlić, H., Puljiz, Ž., Žučko, J., Dumanić, P., et al. (2023) · Nutrients · doi:10.3390/nu15102236 · Cited by 83
The potential of novel biomarkers to improve risk prediction of type 2 diabetes
Herder, C., Kowall, B., Tabák, Á. G., & Rathmann, W. (2013) · Diabetologia · doi:10.1007/s00125-013-3061-3 · Cited by 81
Regulatory Connections between Iron and Glucose Metabolism
Fillebeen, C., Lam, N. H., Chow, S., Botta, A. M., Sweeney, G., & Pantopoulos, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207773 · Cited by 78
Relationship between the lipidome, inflammatory markers and insulin resistance
Wallace, M., Morris, C., O’Grada, C. M., Ryan, M., Dillon, E., Coleman, E., Gibney, E. R., Gibney, M. J., Roche, H. M., & Brennan, L. (2014) · Molecular BioSystems · doi:10.1039/c3mb70529c · Cited by 88
Genetic Regulation of Plasma Lipid Species and Their Association with Metabolic Phenotypes
Jha, P., McDevitt, M. T., Halilbasic, E., Williams, E. G., Quirós, P. M., Gariani, K., Sleiman, M. S. B., Gupta, R., Ulbrich, A., Jochem, A., et al. (2018) · Cell Systems · doi:10.1016/j.cels.2018.05.009 · Cited by 72
“Understanding the physiological contributions of these diverse lipids is important because species within the same class have differential association with disease states (Puri et al., 2009; Quehenberger and Dennis, 2011; Rhee et al., 2011).”
BackgroundResultAbnormal Myocardial Dietary Fatty Acid Metabolism and Diabetic Cardiomyopathy
Carpentier, A. C. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.12.029 · Cited by 71
Nie, Q., Xing, M., Chen, H., Hu, J., & Nie, S. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b03430 · Cited by 69
Imamura, F., Sharp, S. J., Koulman, A., Schulze, M. B., Kröger, J., Griffin, J. L., Huerta, J. M., Guevara, M., Sluijs, I., Agudo, A., et al. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002409 · Cited by 75
BMI and lipidomic biomarkers with risk of gestational diabetes in pregnant women
Wang, Y., Wu, P., Huang, Y., Ye, Y., Yang, X., Sun, F., Ye, Y., Lai, Y., Ouyang, J., Wu, L., et al. (2022) · Obesity · doi:10.1002/oby.23517 · Cited by 68
“Similarly, TG and LPC with lower carbon number and double bond content were positively associated with an increased risk of type 2 diabetes, whereas higher carbon number and double bond were associated with a decreased risk [35].”
BackgroundBai, Z., Huang, X., Wu, G., Ye, H., Huang, W., Nie, Q., Chen, H., Yin, J., Chen, Y., & Nie, S. (2022) · Food Chemistry · doi:10.1016/j.foodchem.2022.134598 · Cited by 69
Bellot, P. E. N. R., Moia, M. N., Reis, B. Z., Pedrosa, L. F. C., Tasić, L., Barbosa, F., & Sena‐Evangelista, K. C. M. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202200568 · Cited by 66
Plasma metabolite profile for primary open-angle glaucoma in three US cohorts and the UK Biobank
Zeleznik, O. A., Kang, J. H., Lasky-Su, J., Eliassen, A. H., Frueh, L., Clish, C. B., Rosner, B. A., Elze, T., Hysi, P., Khawaja, A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38466-w · Cited by 66
Self-citationArora, T., Velagapudi, V., Pournaras, D. J., Welbourn, R., le Roux, C. W., Orešič, M., & Bäckhed, F. (2015) · PLOS ONE · doi:10.1371/journal.pone.0126401 · Cited by 63
“In addition, pre-surgery levels of TGs with long-chain fatty acids (54:2, 55:1, 56:3 and 57:2) and phospholipids with long-chain fatty acids [PC (38:7) and PE (36:4, 38:4)] were higher in subjects with diabetes remission, consistent with previous reports correlating elevated levels of lipid species with higher chain l…”
BackgroundResultGarcía-Fontana, B., Morales, S., Díaz, C., Rozas-Moreno, P., Genilloud, O., Pérez, F. V., del Palacio, J. P., & Muñoz‐Torres, M. (2015) · Talanta · doi:10.1016/j.talanta.2015.10.070 · Cited by 66
Vaishya, S., Sarwade, R. D., & Seshadri, V. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00180 · Cited by 72
“(2011) have shown that longer chain triacylglycerol (TAGs) are associated with a decreased risk of diabetes, whereas the short chain TAGs are associated with an increased risk, their levels positively correlate with insulin resistance (121).”
BackgroundYamada, C., Kondo, M., Kishimoto, N., Shibata, T., Nagai, Y., Imanishi, T., Oroguchi, T., Ishii, N., & Nishizaki, Y. (2015) · Journal of Diabetes Investigation · doi:10.1111/jdi.12323 · Cited by 68
Lipidomics—Reshaping the Analysis and Perception of Type 2 Diabetes
Markgraf, D. F., Al‐Hasani, H., & Lehr, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111841 · Cited by 69
“[114] T2D prospective study, 12 year follow-up (m/f) Plasma TAG (low carbon & double bond number) TAG (high carbon & double bond number)”
MethodPapandreou, C., Bulló, M., Zheng, Y., Ruiz-Canela, M., Yu, E., Guasch-Ferré, M., Toledo, E., Clish, C., Corella, D., Estruch, R., et al. (2018) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy058 · Cited by 61
Self-citationSystems Epidemiology: A New Direction in Nutrition and Metabolic Disease Research
Cornelis, M. C., & Hu, F. B. (2013) · Current Nutrition Reports · doi:10.1007/s13668-013-0052-4 · Cited by 67
“In a population sample of men, coffee intake was positively associated with specific classes of SMs and negatively associated with long- and medium-chain acylcarnitines in plasma [119], classes previously linked to reduced and increased risk of T2D, respectively [80, 81, 120–122].”
Pflimlin, E., Bielohuby, M., Korn, M., Breitschopf, K., Löhn, M., Wohlfart, P., Konkar, A., Podeschwa, M., Bärenz, F., Pfenninger, A., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.05.028 · Cited by 61
Rai, S., & Bhatnagar, S. (2017) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2016.0178 · Cited by 64
“…hallmark of T2D is an increase in plasma concentration of FFA (Barber et al., 2012; Boden and Shulman, 2002; Sa-mad et al., 2006), Cer (Haus et al., 2009; Kang et al., 2013; Samad et al., 2006), and TGs enriched with small-chain fatty acid having lower double bond content (Rhee et al., 2011).”
Plasma lipid profiling of tissue-specific insulin resistance in human obesity
van der Kolk, B. W., Vogelzangs, N., Jocken, J. W. E., Valsesia, A., Hankemeier, T., Astrup, A. V., Saris, W. H. M., Arts, I. C. W., van Greevenbroek, M. M. J., & Blaak, E. E. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0189-8 · Cited by 64
Guerra, S., Mocciaro, G., & Gastaldelli, A. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13695 · Cited by 65
Role of Nutrient-Sensing Signals in the Pathogenesis of Diabetic Nephropathy
Kume, S., Koya, D., Uzu, T., & Maegawa, H. (2014) · BioMed Research International · doi:10.1155/2014/315494 · Cited by 60
“A high fructose intake rather than glucose [62], and ingestion of high concentrations of plasma branched-chain amino acids [63], and saturated fatty acids rather than polyunsaturated fatty acids [64] are independent risk factors for developing insulin resistance and diabetes.”
BackgroundLovrić, A., Granér, M., Björnson, E., Arif, M., Benfeitas, R., Nyman, K., Ståhlman, M., Pentikäinen, M. O., Lundbom, J., Hakkarainen, A., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-31865-w · Cited by 65
Systems biology approaches to study lipidomes in health and disease
Alves, M. A., Lamichhane, S., Dickens, A. M., McGlinchey, A. J., Ribeiro, H. C., Sen, P., Wei, F., Hyötyläinen, T., & Orešič, M. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158857 · Cited by 65
Izadpanah, A., Barnard, R. J., Almeda, A. J. E., Baldwin, G., Bridges, S., Shellman, E. R., Burant, C., & Roberts, C. (2012) · American Journal of Physiology. Endocrinology and Metabolism · doi:10.1152/ajpendo.00190.2012 · Cited by 74
“In addition, we noted a 24% drop in 14:0 FA levels, and shorter-chain saturated FA levels, especially 14:0, in TG have been associated with an increased risk of type 2 diabetes (34).”
BackgroundSlieker, R. C., Donnelly, L. A., Fitipaldi, H., Bouland, G. A., Giordano, G. N., Åkerlund, M., Gerl, M. J., Ahlqvist, E., Ali, A., Dragan, I., et al. (2021) · Diabetes · doi:10.2337/db20-1281 · Cited by 57
“(24) In addition, lipids that were associated with increased diabetes risk were generally saturated or monounsaturated fatty acids.(24) MOD was further characterized by upregulation of leptin, growth hormone receptor and multiple interleukins and IL-1Ra.”
BackgroundResultInfluentialMetabolic characterization of hypertrophic cardiomyopathy in human heart
Wang, W., Wang, J., Yao, K., Wang, S., Nie, M., Zhao, Y., Wang, B., Pang, H., Xu, J., Wu, G., et al. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-022-00057-1 · Cited by 60
Mass Spectrometry-based Lipidomics and Its Application toBiomedical Research
Wu, Z., Shon, J. C., & Liu, K.-H. (2014) · Journal of Lifestyle Medicine · doi:10.15280/jlm.2014.4.1.17 · Cited by 62
“According to re- cently released data from Rhee [8], lipids of lower carbon number and double bond content (44:1, 46:1, 48:0, 48:1, 50:0, 52:1) were associated with an increased risk of dia- betes, whereas lipids of higher carbon number and double bond content (56:9, 58:10, 60:12) were associated decreased risk of dia…”
BackgroundInfluentialHuang, T., Zeleznik, O. A., Poole, E. M., Clish, C. B., Deik, A., Scott, J. M., Vetter, C., Schernhammer, E. S., Brunner, R. L., Hale, L. E., et al. (2018) · International Journal of Epidemiology · doi:10.1093/ije/dyy234 · Cited by 58
Self-citationFurse, S., White, S. L., Meek, C. L., Jenkins, B., Petry, C. J., Vieira, M. C., Ozanne, S. E., Dunger, D. B., Poston, L., & Koulman, A. (2019) · Molecular Omics · doi:10.1039/c9mo00117d · Cited by 62
Rahman, M. L., Feng, Y. A., Fiehn, O., Albert, P. S., Tsai, M. Y., Zhu, Y., Wang, X., Ayele, F. T., Liang, L., & Zhang, C. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001551 · Cited by 65
Zhu, H., Bai, M., Xie, X., Wang, J., Weng, C., Dai, H., Chen, J., Han, F., & Lin, W. (2022) · Nutrients · doi:10.3390/nu14163345 · Cited by 59
“Additionally, studies have shown that disorders of carbohydrate (fructose and glucose) metabolites or lipid (glycerophospholipids, sphingomyelins, and triglycerides) metabolites may prospectively correlate with diabetes risk [4,5].”
BackgroundUsing metabolomics to assess myocardial metabolism and energetics in heart failure
Turer, A. T. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.08.025 · Cited by 57
“Peripheral acylcarnitine and fatty acid profiling have been applied to the study of ischemic heart disease [65], ischemia– reperfusion injury [48], weight loss [66], and diabetes risk [67].”
BackgroundBadoud, F., Lam, K. P., Perreault, M., Zulyniak, M. A., Britz‐McKibbin, P., & Mutch, D. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134613 · Cited by 62
“Recent evidence has shown relationships between FAs, insulin sensitivity indices, and T2D risk [32]; therefore, we evaluated if FAs were also associated with parameters of insulin sensitivity in our study.”
BackgroundMartínez‐González, M. Á., Ruiz‐Canela, M., Hruby, A., Liang, L., Trichopoulou, A. D., & Hu, F. B. (2016) · Journal of Nutrition · doi:10.3945/jn.115.219147 · Cited by 63
“In a nested case-control analysis, cholesterol esters, sphingomyelins, lysophosphatidylcholines, phosphatidylcholines, lysophosphatidylethanolamines, and TGs with a lower carbon number and lower double bond content were associated with a higher risk of diabetes, whereas lipids of higher carbon number and higher double…”
BackgroundMamtani, M., Kulkarni, H. R., Wong, G., Weir, J. M., Barlow, C. K., Dyer, T. D., Almasy, L. A., Mahaney, M. C., Comuzzie, A. G., Glahn, D. C., et al. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0234-3 · Cited by 63
“Lastly, the TG(16:0/18:0/18:1) has been reported as a prominent triacylglycerol species that discriminated between cases and controls of diabetes in the Framingham Offspring Study participants [58].”
BackgroundMetabolomics identifies shared lipid pathways in independent amyotrophic lateral sclerosis cohorts
Goutman, S. A., Guo, K., Savelieff, M. G., Patterson, A., Sakowski, S. A., Habra, H., Karnovsky, A., Hur, J., & Feldman, E. L. (2022) · Brain · doi:10.1093/brain/awac025 · Cited by 51
“Studies show lack of dietary effects on the plasma lipidomics profile 24 and low intra-individual variation in non-fasted plasma 25 ; thus, deep grained plasma metabolomics/lipidomics signatures of disease exist, independent of diet.”
DeMarco, V. G., Ford, D. A., Henriksen, E. J., Aroor, A. R., Johnson, M. S., Habibi, J., Ma, L., Yang, M. J., Albert, C. J., Lally, J. W., et al. (2012) · Endocrinology · doi:10.1210/en.2012-1835 · Cited by 57
Lipidomics and Biomarker Discovery in Kidney Disease
Afshinnia, F., Rajendiran, T. M., Wernisch, S., Soni, T., Jadoon, A., Karnovsky, A., Michailidis, G. C., & Pennathur, S. (2018) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2018.01.004 · Cited by 53
Charidemou, E., Ashmore, T., Li, X., McNally, B. D., West, J. A., Liggi, S., Harvey, M., Orford, E., & Griffin, J. L. (2019) · JCI Insight · doi:10.1172/jci.insight.124819 · Cited by 52
“The latest nutritional transition from traditional to Western-style diets (rich in sugar, fat, and protein from red meat) has led to a growing prevalence of NAFLD and T2DM (3).”
BackgroundInfluentialMetabolites Associated With Lean Mass and Adiposity in Older Black Men
Murphy, R. A., Moore, S. C., Playdon, M. C., Meirelles, O., Newman, A. B., Milijkovic, I., Kritchevsky, S. B., Schwartz, A. V., Goodpaster, B. H., Sampson, J. N., et al. (2017) · The Journals of Gerontology Series A · doi:10.1093/gerona/glw245 · Cited by 55
Self-citationNew insight into the mechanism of POP-induced obesity: Evidence from DDE-altered microbiota
Liang, Y., Liu, D., Zhan, J., Luo, M., Han, J., Wang, P., & Zhou, Z. (2019) · Chemosphere · doi:10.1016/j.chemosphere.2019.125123 · Cited by 57
Anjos, S., Feiteira, E., Cerveira, F., Melo, T., Reboredo, A., Colombo, S., Dantas, R., da Costa, E. V., Moreira, A. S. P., Santos, S. A. O., et al. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00249 · Cited by 54
Huang, T.-Y., Balasubramanian, R., Yao, Y., Clis, C. B., Shadyab, A., Liu, B.-Y., Tworoger, S., Rexrode, K., Manson, J., Kubzansky, L., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00870-9 · Cited by 41
Self-citationKim, E. Y., Lee, J. W., Lee, M. Y., Kim, S. H., Mok, H. J., Ha, K., Ahn, Y. M., & Kim, K. P. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.04.029 · Cited by 49
Metabolomics of Diabetic Retinopathy
Liew, G., Zhou, L., Tan, G. S. W., Joachim, N., Ho, I., Wong, T. Y., Mitchell, P., Gopinath, B., & Crossett, B. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0939-3 · Cited by 51
Fernandez, C., Surma, M. A., Klose, C. D., Gerl, M. J., Ottosson, F. A., Ericson, U., Oskolkov, N., Ohro-Melander, M., Simons, K., & Melander, O. (2019) · Diabetes Care · doi:10.2337/dc19-1199 · Cited by 54
“Our results also confirmprevious studies that have established that DAG and TAG, including TAG 48:0;0, are associated with a higher risk of T2DM (6,8,9).”
Result
Metadata
- Authors
- Rhee, E. P., Cheng, S., Larson, M. G., Walford, G. A., Lewis, G. D., McCabe, E., Yang, E., Farrell, L., Fox, C. S., O’Donnell, C. J., Carr, S. A., Vasan, R. S., Florez, J. C., Clish, C. B., Wang, T. J., & Gerszten, R. E.
- Affiliations
- Broad Institute (US)
- Boston University (US)
- Massachusetts General Hospital (US)
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2011-04-01
- Volume
- 121
- Issue
- 4
- Pages
- 1402-1411
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3069773
- OpenAlex
- W2169156123
- Cited by
- 647
- References
- 33
- Citations by year
- 2026: 17 · 2025: 31 · 2024: 48 · 2023: 54 · 2022: 65 · 2021: 57 · 2020: 52 · 2019: 47 · 2018: 38 · 2017: 41 · 2016: 44 · 2015: 33 · 2014: 40 · 2013: 45 · 2012: 25
- FWCI
- 31.43
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Doris Duke Charitable Foundation (N01-HC-25195)
- Donald W. Reynolds Foundation
- American Heart Association (N01-HC-25195)
- Endocrine Fellows Foundation
- Fondation Leducq
- National Institutes of Health (n01hc025195-11-0-0, N01-HC 25195)
- National Heart, Lung, and Blood Institute (N01‐HC25195, R01HL081572, N01-HC-025195, K23HL091106)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK088214, T32-DK-00754023, T32DK007540, R01-DK-HL-081572, R01DK081572)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- type 2 diabetes, insulin resistance, triglycerides, lipidomics, plasma lipids, acyl chain length, double bond content, dyslipidemia, diabetes risk prediction, oral glucose tolerance test, insulin action, acute exercise
- MeSH terms
- Adult, Aged, Diabetes Mellitus, Type 2, Exercise Test, Female, Glucose Tolerance Test, Humans, Insulin, Insulin Resistance, Lipids, Male, Middle Aged, Predictive Value of Tests, Risk Factors, Triglycerides, Molecular Structure, Biomarkers, Case-Control Studies, Dyslipidemias
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.